tiprankstipranks
Trending News
More News >
Polyrizon Ltd. (PLRZ)
NASDAQ:PLRZ
US Market

Polyrizon Ltd. (PLRZ) Price & Analysis

Compare
182 Followers

PLRZ Stock Chart & Stats

$0.52
-$0.06(-3.81%)
At close: 4:00 PM EST
$0.52
-$0.06(-3.81%)

Polyrizon Ltd. News

PLRZ FAQ

What was Polyrizon Ltd.’s price range in the past 12 months?
Polyrizon Ltd. lowest stock price was $2.88 and its highest was $4200.00 in the past 12 months.
    What is Polyrizon Ltd.’s market cap?
    Polyrizon Ltd.’s market cap is $11.52M.
      When is Polyrizon Ltd.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Polyrizon Ltd.’s earnings last quarter?
      Currently, no data Available
      Is Polyrizon Ltd. overvalued?
      According to Wall Street analysts Polyrizon Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Polyrizon Ltd. pay dividends?
        Polyrizon Ltd. does not currently pay dividends.
        What is Polyrizon Ltd.’s EPS estimate?
        Polyrizon Ltd.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Polyrizon Ltd. have?
        Polyrizon Ltd. has 1,593,946 shares outstanding.
          What happened to Polyrizon Ltd.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Polyrizon Ltd.?
          Currently, no hedge funds are holding shares in PLRZ
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Polyrizon Ltd.

            Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
            Similar Stocks
            Company
            Price & Change
            Follow
            Enveric Biosciences
            Artelo Biosciences
            Dermata Therapeutics
            SciSparc Ltd.
            Conduit Pharmaceuticals
            Popular Stocks